- Home
- LXRX vs NHS Comparison
LXRX vs NHS Comparison
Compare LXRX & NHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- NHS
- Stock Information
- Founded
- LXRX 1995
- NHS 2003
- Country
- LXRX United States
- NHS United States
- Employees
- LXRX N/A
- NHS N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- NHS Trusts Except Educational Religious and Charitable
- Sector
- LXRX Health Care
- NHS Finance
- Exchange
- LXRX Nasdaq
- NHS Nasdaq
- Market Cap
- LXRX 228.8M
- NHS 221.6M
- IPO Year
- LXRX 2000
- NHS N/A
- Fundamental
- Price
- LXRX $0.75
- NHS $7.55
- Analyst Decision
- LXRX Buy
- NHS
- Analyst Count
- LXRX 4
- NHS 0
- Target Price
- LXRX $3.67
- NHS N/A
- AVG Volume (30 Days)
- LXRX 3.7M
- NHS 111.8K
- Earning Date
- LXRX 07-31-2025
- NHS 01-01-0001
- Dividend Yield
- LXRX N/A
- NHS 13.44%
- EPS Growth
- LXRX N/A
- NHS N/A
- EPS
- LXRX N/A
- NHS N/A
- Revenue
- LXRX $31,213,000.00
- NHS N/A
- Revenue This Year
- LXRX N/A
- NHS N/A
- Revenue Next Year
- LXRX N/A
- NHS N/A
- P/E Ratio
- LXRX N/A
- NHS N/A
- Revenue Growth
- LXRX 1251.21
- NHS N/A
- 52 Week Low
- LXRX $0.28
- NHS $6.95
- 52 Week High
- LXRX $2.45
- NHS $9.17
- Technical
- Relative Strength Index (RSI)
- LXRX 61.01
- NHS 51.22
- Support Level
- LXRX $0.64
- NHS $7.54
- Resistance Level
- LXRX $0.77
- NHS $7.71
- Average True Range (ATR)
- LXRX 0.06
- NHS 0.06
- MACD
- LXRX 0.00
- NHS 0.00
- Stochastic Oscillator
- LXRX 76.47
- NHS 53.57
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
About NHS Neuberger Berman High Yield Strategies Fund
Neuberger Berman High Yield Strategies Fund is closed-end management investment company. It seeks to achieve its investment objective by investing, under normal market conditions, a majority of its total assets in high yield debt securities of U.S. and foreign issuers.